Symbyax side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Symbyax (fluoxetine hydrochloride; olanzapine). Common side effects include diabetes mellitus among females and completed suicide among males.
The phase IV clinical study is created by eHealthMe based on 1,347 reports from the FDA, and is updated regularly.
What is Symbyax?
Symbyax has active ingredients of fluoxetine hydrochloride; olanzapine. It is often used in depression. eHealthMe is studying from 1,449 Symbyax users. Check the latest studies of Symbyax.
1,347 people who take Symbyax and have side effects are studied.
What are the common side effects of Symbyax, by gender? *
What are the common side effects of Symbyax, by age (0-1 to 60+)? *
What are the common side effects of Symbyax, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Symbyax?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on fluoxetine hydrochloride; olanzapine (the active ingredients of Symbyax) and Symbyax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Symbyax:
- Symbyax (1,449 reports)
All Symbyax side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ancef cause Weight Loss? - 2 seconds ago
- Niaspan vs. Lisinopril, side effect and effectiveness comparison - 4 seconds ago
- Levetiracetam and Speech Impairment (Adult) for Women aged 50-59 - 5 seconds ago
- Levetiracetam and Slurred Speech for Women aged 50-59 - 6 seconds ago
- Levetiracetam and Language Impairment for Women aged 50-59 - 6 seconds ago
- Levetiracetam and Impairment Of Speech for Women aged 50-59 - 6 seconds ago
- Levetiracetam and Dysphasia for Women aged 50-59 - 6 seconds ago
- Levetiracetam and Dysarthria for Women aged 50-59 - 7 seconds ago
- Levetiracetam and Aphasia for Women aged 50-59 - 7 seconds ago
- Levetiracetam and Inability To Speak for Women aged 50-59 - 7 seconds ago